China
· Delayed Price · Currency is CNY APT Medical Statistics
Total Valuation
APT Medical has a market cap or net worth of CNY 34.04 billion. The enterprise value is 32.74 billion.
| Market Cap | 34.04B |
| Enterprise Value | 32.74B |
Important Dates
The next estimated earnings date is Thursday, April 2, 2026.
| Earnings Date | Apr 2, 2026 |
| Ex-Dividend Date | Jun 19, 2025 |
Share Statistics
APT Medical has 141.01 million shares outstanding. The number of shares has decreased by -0.09% in one year.
| Current Share Class | 141.01M |
| Shares Outstanding | 141.01M |
| Shares Change (YoY) | -0.09% |
| Shares Change (QoQ) | +0.19% |
| Owned by Insiders (%) | 19.97% |
| Owned by Institutions (%) | 40.33% |
| Float | 71.49M |
Valuation Ratios
The trailing PE ratio is 44.35 and the forward PE ratio is 32.55.
| PE Ratio | 44.35 |
| Forward PE | 32.55 |
| PS Ratio | 14.13 |
| PB Ratio | 11.21 |
| P/TBV Ratio | 13.36 |
| P/FCF Ratio | 59.74 |
| P/OCF Ratio | 38.01 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 35.00, with an EV/FCF ratio of 57.45.
| EV / Earnings | 42.61 |
| EV / Sales | 13.59 |
| EV / EBITDA | 35.00 |
| EV / EBIT | 39.30 |
| EV / FCF | 57.45 |
Financial Position
The company has a current ratio of 5.38, with a Debt / Equity ratio of 0.01.
| Current Ratio | 5.38 |
| Quick Ratio | 3.98 |
| Debt / Equity | 0.01 |
| Debt / EBITDA | 0.02 |
| Debt / FCF | 0.04 |
| Interest Coverage | 589.29 |
Financial Efficiency
Return on equity (ROE) is 27.44% and return on invested capital (ROIC) is 18.91%.
| Return on Equity (ROE) | 27.44% |
| Return on Assets (ROA) | 16.62% |
| Return on Invested Capital (ROIC) | 18.91% |
| Return on Capital Employed (ROCE) | 26.93% |
| Revenue Per Employee | 942,626 |
| Profits Per Employee | 300,708 |
| Employee Count | 2,555 |
| Asset Turnover | 0.77 |
| Inventory Turnover | 1.51 |
Taxes
In the past 12 months, APT Medical has paid 114.02 million in taxes.
| Income Tax | 114.02M |
| Effective Tax Rate | 13.18% |
Stock Price Statistics
The stock price has decreased by -7.88% in the last 52 weeks. The beta is -0.26, so APT Medical's price volatility has been lower than the market average.
| Beta (5Y) | -0.26 |
| 52-Week Price Change | -7.88% |
| 50-Day Moving Average | 284.83 |
| 200-Day Moving Average | 282.86 |
| Relative Strength Index (RSI) | 29.48 |
| Average Volume (20 Days) | 1,109,717 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, APT Medical had revenue of CNY 2.41 billion and earned 768.31 million in profits. Earnings per share was 5.44.
| Revenue | 2.41B |
| Gross Profit | 1.74B |
| Operating Income | 833.10M |
| Pretax Income | 864.95M |
| Net Income | 768.31M |
| EBITDA | 925.22M |
| EBIT | 833.10M |
| Earnings Per Share (EPS) | 5.44 |
Balance Sheet
The company has 1.38 billion in cash and 21.87 million in debt, giving a net cash position of 1.35 billion or 9.60 per share.
| Cash & Cash Equivalents | 1.38B |
| Total Debt | 21.87M |
| Net Cash | 1.35B |
| Net Cash Per Share | 9.60 |
| Equity (Book Value) | 3.04B |
| Book Value Per Share | 21.20 |
| Working Capital | 1.61B |
Cash Flow
In the last 12 months, operating cash flow was 895.61 million and capital expenditures -325.81 million, giving a free cash flow of 569.80 million.
| Operating Cash Flow | 895.61M |
| Capital Expenditures | -325.81M |
| Free Cash Flow | 569.80M |
| FCF Per Share | 4.04 |
Margins
Gross margin is 72.42%, with operating and profit margins of 34.59% and 31.90%.
| Gross Margin | 72.42% |
| Operating Margin | 34.59% |
| Pretax Margin | 35.91% |
| Profit Margin | 31.90% |
| EBITDA Margin | 38.42% |
| EBIT Margin | 34.59% |
| FCF Margin | 23.66% |
Dividends & Yields
This stock pays an annual dividend of 1.21, which amounts to a dividend yield of 0.50%.
| Dividend Per Share | 1.21 |
| Dividend Yield | 0.50% |
| Dividend Growth (YoY) | 26.88% |
| Years of Dividend Growth | 4 |
| Payout Ratio | 22.16% |
| Buyback Yield | 0.09% |
| Shareholder Yield | 0.59% |
| Earnings Yield | 2.26% |
| FCF Yield | 1.67% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on June 19, 2025. It was a forward split with a ratio of 1.45.
| Last Split Date | Jun 19, 2025 |
| Split Type | Forward |
| Split Ratio | 1.45 |
Scores
APT Medical has an Altman Z-Score of 57.05 and a Piotroski F-Score of 7.
| Altman Z-Score | 57.05 |
| Piotroski F-Score | 7 |